Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. - Wikidata - awgldk - TriplyDB

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

http://www.wikidata.org/entity/Q34462030

about

Functions and mechanisms of action of CCN matricellular proteins Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.CCN1/CYR61: the very model of a modern matricellular protein.A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway.Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.Multivariate survival analysis of the patients with recurrent endometrial cancer Cyr61 expression is associated with prognosis in patients with colorectal cancer.Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer.Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells.Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells.The 5' untranslated regions (UTRs) of CCN1, CCN2, and CCN4 exhibit cryptic promoter activity.Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling Expression and clinical significance of connective tissue growth factor in thyroid carcinomas.Connective tissue growth factor mediates TGF-β1-induced low-grade serous ovarian tumor cell apoptosis.Inhibitory effect of dexamethasone on expression of cysteine-rich 61 protein in airway epithelial cells of allergic mouse models.CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.Knockdown of cysteine-rich 61 inhibits proliferation, migration, and invasiveness of prostate carcinoma PC-3 cells Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway

P2860

Q24642303-E6409CEB-7F03-4729-A04A-24E8A02CF5D6 Q28254386-0F8E67BA-CADD-4D64-842F-1587A0533D6A Q28396305-81962472-8BF3-4FAF-8285-E3F3449D0338 Q33597230-A8DFB016-1F63-4F6F-9BAA-AC261D7E824E Q34027926-A97A0863-99B6-49F5-A37B-4A3824481F1E Q34065731-E9ED19E6-66B0-4151-AC26-D3844D146D2F Q34127147-210C0CC7-9D11-4BBB-BF45-89ABB912ED57 Q34649455-E4E0B088-80DC-4136-B066-00A2D51037CF Q34990472-4C980669-CE9B-46BC-846E-F156D0D91F8E Q35113999-1A3A8A0D-868B-4464-BA44-6B1195279BB6 Q35236809-EED9C2F1-5B46-4126-9C22-83E6725F6715 Q36004674-917A0514-82FC-4BE4-85DD-8BF04C14B6E1 Q36151613-E2B73AE6-1D52-4FC4-8EED-44F389B066E4 Q36578825-7C6EB4AB-CD3A-4CA3-BCA8-CA2B47AC445A Q36689039-AD0A2867-5544-4568-914A-C2422C927FBF Q36738929-6FA652FD-09B8-4E5A-A6D1-6161D209C9C7 Q37060790-7EEA054A-892C-4E27-BFAC-DE8C8552E733 Q37321195-1E85089B-D0E4-42EF-A2EB-CB1768C6C1F4 Q37705939-6CDB09C4-3BCE-4199-BC2B-951C93C2B97F Q38212057-9610DCCF-5C3C-4885-94BB-20A4A1E175EA Q38615651-2913BB65-818D-4A2B-A3D3-95D5157ADF15 Q38869147-2BFFB5D0-1788-4142-B257-D8A825DC68CC Q39321392-4162C663-3C1F-42A6-B8E7-5F6851912A82 Q39462703-98DCE555-701E-40BD-876D-D05CA935B7C2 Q39594126-76A023D9-B712-4448-ADAE-9CF330221BA5 Q40076490-64221E75-4A24-48F3-B4FF-16598892DD82 Q40076496-C064663C-5908-4F78-91C8-FE0219A4B39A Q40342407-20DEB1A3-2809-4115-9D56-4E9E27A08BB8 Q41980569-A8A87601-6B4D-4FFB-935D-111FC2BED751 Q42715876-D19008AA-A25E-4972-9059-D255C6A318AD Q44734130-04AAAD6F-C6FB-4200-9108-B794F536AEB8 Q46387742-12223A8A-AAD0-4730-A58F-C8681B71CE0F Q53085874-7B59A472-0DA6-4A48-9E6E-E1D05FF04D03 Q54198095-AE399052-B681-4765-9F0E-E2D1BDB8086B Q58139757-4CD1B3C9-C92D-4DDE-A96D-EE2362A25C21 Q58775646-273D0C54-B57E-4EAF-B9BD-A9EF319361ED

P2860

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

http://www.wikidata.org/entity/Q34462030

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@ast

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@en

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@nl

type

label

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@ast

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@en

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@nl

prefLabel

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@ast

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@en

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@nl

P1433

Q34462030-51A559EA-DC01-45A1-BAE6-7C00339BC98C

P1476

Q34462030-34B42C8B-9D27-4A54-BBCE-E3418748E019

P2093

Q34462030-247AC6E9-2794-42D5-83B7-E748CE11CFA8

Q34462030-301D481E-8890-499F-B3D2-4B59E8C5E8F7

Q34462030-36CCAADA-DC63-4880-A40A-771435CE9C90

Q34462030-5C482F71-3266-4FCA-B64B-2209CF9C8976

Q34462030-7DBB9F4F-A8A8-47FE-918C-5B1B1B9A8011

Q34462030-8A715BEA-724A-48E8-8CE8-9A0F1BE721EA

Q34462030-A0898C2B-525B-4C03-8DA9-9C0BAB329D6B

Q34462030-E22083CC-6C8F-4052-B5FA-B3E4E99D10B7

Q34462030-F5B71DCA-4581-4E23-BD38-16977C725861

Q34462030-F7C236FC-D146-4FFF-8DD2-7A74E8F87179

P304

Q34462030-19F5BFA6-4259-4ED9-B3D7-D9E9A344FA16

P31

Q34462030-58AA82A5-0428-445E-9309-733A0D86F71F

P356

Q34462030-C29402CE-6F04-491C-9FF4-E037CCDE4D75

P407

Q34462030-9FB2A265-B6A3-4B2C-AEC8-C8744A7B3078

P433

Q34462030-380F2E4F-190F-4E83-8273-EFBFE6786691

P478

Q34462030-E9B1664E-5893-4C47-99C2-2BFB8F706A3E

P577

Q34462030-688CF295-D524-4B94-92B6-06E7EDDC1AD5

P698

Q34462030-7BD6C78F-BCCF-4C91-9D10-1D24019896A4

P356

1078-0432.CCR-05-0231

P1433

Clinical Cancer Research

P1476

Ovarian carcinomas: CCN genes ...... proliferation of these cells.

@en

P2093

Carl Miller

http://www.w3.org/2001/XMLSchema#string

Diane Scott

http://www.w3.org/2001/XMLSchema#string

Dong Xie

http://www.w3.org/2001/XMLSchema#string

Dong Yin

http://www.w3.org/2001/XMLSchema#string

H Phillip Koeffler

http://www.w3.org/2001/XMLSchema#string

Hani Gabra

http://www.w3.org/2001/XMLSchema#string

Heming Wang

http://www.w3.org/2001/XMLSchema#string

Johathan W Said

http://www.w3.org/2001/XMLSchema#string

Miriam L Popoviciu

http://www.w3.org/2001/XMLSchema#string

Sigal Gery

http://www.w3.org/2001/XMLSchema#string

P304

7243-7254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-0231

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16243794

http://www.w3.org/2001/XMLSchema#string